Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 03/28/18

Austin Doyle, MD

Physician

Dr. Doyle received his medical degree from the University of Maryland School of Medicine, where he completed internship and residency training in Internal Medicine. Dr. Doyle completed a medical oncology fellowship in the NCI-Navy Medical Oncology Branch of NCI. He joined the faculty of the Greenebaum Cancer Center, at the University of Maryland School of Medicine, and rose to the rank of Professor of Medicine and Oncology. Dr. Doyle’s significant laboratory work involved membrane transporters involved in cancer multidrug resistance, and his clinical work was in thoracic and gastrointestinal malignancies. Since joining the Investigational Drug Branch of CTEP, Dr. Doyle has developed a portfolio of agents including signal transduction inhibitors, mitosis-directed therapeutics, cell cycle-regulatory agents, and drugs involved with DNA damage response.

Contact Information:
National Cancer Institute
9609 Medical Center Dr., MSC 9739
For USPS: Bethesda, MD 20892-9739
For Express and Courier: Rockville, MD 20850
Phone: 240-276-6565
Fax: 240-276-7894
E-mail: doylela@mail.nih.gov

About the Acting Branch Chief

Jeffrey A. Moscow, MD Jeffrey A. Moscow, MD, joined the CTEP Investigational Drug Branch (IDB) in January 2014, after serving part time since August 2012. Prior to joining CTEP, he was Children’s Miracle Network Professor of Pediatrics, Chief of Pediatric Hematology-Oncology, Vice Chair of Pediatrics, and co-leader of the Experimental Therapeutics Program of the Markey Cancer Center, all at the University of Kentucky. More…